A thickening fiber from a legume seed. Its most consistent effect is a meaningful drop in total and harmful cholesterol. Blood sugar findings disagree. The enzyme-treated version steadies stool form, reduces laxative reliance and eases bloating. It does not produce weight loss. Gas and cramping are common; blockage and reduced medication uptake are avoidable. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | < 70 mg/dL for those optimizing cardiovascular risk | The primary measurable benefit |
| Apolipoprotein B | < 60 mg/dL | Counts every artery-damaging particle, not just cholesterol carried |
| Hemoglobin A1c | 4.8–5.4% | Detects whether the contested glycemic effect is present in this individual |
| Fasting insulin | 2–5 µIU/mL | Moves earlier than glucose and shows whether post-meal load truly dropped |
| Ferritin | 50–150 ng/mL (men), 40–120 ng/mL (women) | Detects the mineral-binding side effect before symptoms appear |
| Serum zinc | 90–120 µg/dL | Second mineral most affected by viscous fiber binding |
| Bristol Stool Form Scale | Type 3–4 on most days | The fastest-responding and most sensitive marker of effect |
Cadence: Baseline panel before starting; lipid panel and apolipoprotein B at eight weeks, then at six and twelve months; hemoglobin A1c at twelve weeks, thereafter every six months; ferritin and zinc at six months with daily viscous dosing.